Last reviewed · How we verify
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
The investigators' purpose was to assess the feasibility of dosage individualization of the commonly used antineoplastic drugs and anti-infective drugs in children with hematoplastic disease.
Details
| Lead sponsor | Wei Zhao |
|---|---|
| Phase | PHASE4 |
| Status | RECRUITING |
| Enrolment | 1500 |
| Start date | Sun Jan 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Dec 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Hematological Neoplasms
Interventions
- Bortezomib
- Eltrombopag
- Imatinib
- dasatinib
- Pegaspargase
- Anti-Infective Drugs
- PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor
Countries
China